Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans
Author
dc.contributor.author
Simon, Felipe
Author
dc.contributor.author
Varela Lekanda, Diego
es_CL
Author
dc.contributor.author
Cabello Verrugio, Claudio
es_CL
Admission date
dc.date.accessioned
2014-03-06T20:05:50Z
Available date
dc.date.available
2014-03-06T20:05:50Z
Publication date
dc.date.issued
2013
Cita de ítem
dc.identifier.citation
Cellular Signalling 25 (2013) 1614–1624
en_US
Identifier
dc.identifier.other
doi 10.1016/j.cellsig.2013.03.023
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129286
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
The transient receptor potential melastatin (TRPM) protein family is an extensive group of ion channels
expressed in several types of mammalian cells. Many studies have shown that these channels are crucial
for performing several physiological functions. Additionally, a large body of evidence indicates that these
channels are also involved in numerous human diseases, known as channelopathies.
A characteristic event frequently observed during pathological states is the raising in intracellular oxidative
agents over reducing molecules, shifting the redox balance and inducing oxidative stress. In particular,
three members of the TRPM subfamily, TRPM2, TRPM4 and TRPM7, share the remarkable feature that their
activities are modulated by oxidative stress.
Because of the increase in oxidative stress, these TRPM channels function aberrantly, promoting the onset
and development of diseases.
Increases, absences, or modifications in the function of these redox-modulated TRPM channels are associated
with cell dysfunction and human pathologies. Therefore, the effect of oxidative stress on ion channels becomes
an essential part of the pathogenic mechanism. Thus, oxidative stress-modulated ion channels are
more susceptible to generating pathological states than oxidant-independent channels.
This review examines the most relevant findings regarding the participation of the oxidative stress-modulated
TRPMion channels, TRPM2, TRPM4, and TRPM7, in human diseases. In addition, the potential roles of these channels
as therapeutic tools and targets for drug design are discussed.